Where does ISPC stock trade?

iSpecimen Inc. (ISPC) is listed on NASDAQ.

What sector and industry is ISPC in?

iSpecimen Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.

When did iSpecimen Inc. go public?

iSpecimen Inc. (ISPC) completed its IPO in 2021.

What are analysts saying about ISPC?

iSpecimen Inc. has had 2 recent analyst actions on file. The most recent action was from Craig-Hallum: Buy with a $2000.00 price target on 2022-01-04. Recent price targets range from $1200.00 to $2000.00.

What companies are similar to ISPC?

Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), MEDP (Medpace Holdings Inc.), PPD (PPD, Inc.), CRL (Charles River Laboratories International Inc.). Compare ISPC side-by-side with any of them on Quantisnow.

How can I track ISPC on Quantisnow?

Quantisnow aggregates iSpecimen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISPC to receive live email and push alerts on every new disclosure.

ISPC

NASDAQ

iSpecimen Inc.

SectorHealth CareIndustryBiotechnology: Commercial Physical & Biological ResarchIPO2021

$1.59+0.02 (+1.27%)

News25/Ratings2

News · 26 weeks33+125%

2026-03-012026-08-23

Mix1890d

SEC Filings13(72%)
Offering3(17%)
Other2(11%)

Latest news

25 items

5dPR
iSpecimen Completes Large-Scale International Cancer Research Order; Samples Shipped Within Three Weeks
Woburn, MA, Aug. 20, 2026 (GLOBE NEWSWIRE) -- iSpecimen, a provider of human biospecimens, recently completed an international cancer research project involving hundreds of cancer blood specimens, with the samples shipped within three weeks of receiving the purchase order. The project involved the coordination of large-scale biospecimen sourcing and fulfillment on an accelerated timeline. Through its network of healthcare and research partners, iSpecimen coordinated the sourcing and collection of the required specimens and managed international fulfillment to meet the project's timeline. iSpecimen maintains a global and domestic network of healthcare institutions, laboratories, biobanks,
11dSEC
iSpecimen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
8-K - iSpecimen Inc. (0001558569) (Filer)
11dSEC
SEC Form 10-Q filed by iSpecimen Inc.
10-Q - iSpecimen Inc. (0001558569) (Filer)
14dSEC
iSpecimen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits
8-K - iSpecimen Inc. (0001558569) (Filer)
18dSEC
iSpecimen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - iSpecimen Inc. (0001558569) (Filer)
18dPR
iSpecimen Inc. Announces Closing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
WOBURN, Mass., Aug. 07, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the closing of its previously announced public offering of an aggregate of 996,231 shares of the Company’s common stock and pre-funded warrants to purchase up to an aggregate of 2,849,923 shares of common stock, for an aggregate purchase price of approximately $5.0 million. The Company intends to use the proceeds of the offering for repayment of outstanding liabilities, potential acquisitions of assets or investments in
18dPR
E.F. Hutton & Co. Acts as Acts as Exclusive Placement Agent for $5.0 Million Public Offering for iSpecimen
NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), a leading investment banking and financial advisory firm, today announced that it served as the exclusive placement agent in connection with the $5 million public offering for iSpecimen Inc. (NASDAQ:ISPC), an online global marketplace that connects researchers requiring biospecimens for medical research with a network of healthcare specimen providers. The offering provides iSpecimen with additional capital to support its strategic priorities, including repayment of outstanding liabilities, potential acquisitions and investments, marketing initiatives, and general corporate purposes. The transaction marks E.F.
18dSEC
SEC Form 424B4 filed by iSpecimen Inc.
424B4 - iSpecimen Inc. (0001558569) (Filer)
19dPR
iSpecimen Inc. Announces Pricing of $5 Million Public Offering of Common Stock and Pre-Funded Warrants
WOBURN, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today the pricing of its public offering of approximately $5 million of the Company’s common stock, and/or pre-funded warrants to purchase shares of common stock at a public offering price of $1.30 per share (or $1.2999 per pre-funded warrant, which is equal to the public offering price per share minus the $0.0001 per share exercise price of each pre-funded warrant). The Company intends to use the proceeds of the offering for
25dSEC
SEC Form EFFECT filed by iSpecimen Inc.
EFFECT - iSpecimen Inc. (0001558569) (Filer)
40dSEC
Amendment: SEC Form S-1/A filed by iSpecimen Inc.
S-1/A - iSpecimen Inc. (0001558569) (Filer)
42dSEC
iSpecimen Inc. filed SEC Form 8-K: Other Events
8-K - iSpecimen Inc. (0001558569) (Filer)
50dSEC
Amendment: SEC Form S-1/A filed by iSpecimen Inc.
S-1/A - iSpecimen Inc. (0001558569) (Filer)
62dSEC
SEC Form S-1 filed by iSpecimen Inc.
S-1 - iSpecimen Inc. (0001558569) (Filer)
68dSEC
SEC Form EFFECT filed by iSpecimen Inc.
EFFECT - iSpecimen Inc. (0001558569) (Filer)
82dSEC
SEC Form S-3 filed by iSpecimen Inc.
S-3 - iSpecimen Inc. (0001558569) (Filer)
85dSEC
iSpecimen Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8-K - iSpecimen Inc. (0001558569) (Filer)
88dSEC
iSpecimen Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
8-K - iSpecimen Inc. (0001558569) (Filer)
99dSEC
SEC Form DEFA14A filed by iSpecimen Inc.
DEFA14A - iSpecimen Inc. (0001558569) (Filer)
103dSEC
SEC Form D filed by iSpecimen Inc.
D - iSpecimen Inc. (0001558569) (Filer)
104dSEC
iSpecimen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - iSpecimen Inc. (0001558569) (Filer)
105dPR
E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. ("E.F. Hutton"), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers. This transaction represents E.F. Hutton's latest financing completed with iSpecimen. In December 2025, E.F. Hutton also acted as the exclusive placement agent in connection with a separate private placement for
108dPR
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement
May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (NASDAQ:ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the offering, the Company will issue 488,281 shares of common stock (the "Shares") at a purchase price of $5.12 per Share. In lieu of Shares that would otherwise result i
116dSEC
iSpecimen Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
8-K - iSpecimen Inc. (0001558569) (Filer)
134dSEC
iSpecimen Inc. filed SEC Form 8-K: Other Events
8-K - iSpecimen Inc. (0001558569) (Filer)

ISPC FAQ

6 questions

Where does ISPC stock trade?
iSpecimen Inc. (ISPC) is listed on NASDAQ.
What sector and industry is ISPC in?
iSpecimen Inc. operates in the Health Care sector, Biotechnology: Commercial Physical & Biological Resarch industry.
When did iSpecimen Inc. go public?
iSpecimen Inc. (ISPC) completed its IPO in 2021.
What are analysts saying about ISPC?
iSpecimen Inc. has had 2 recent analyst actions on file. The most recent action was from Craig-Hallum: Buy with a $2000.00 price target on 2022-01-04. Recent price targets range from $1200.00 to $2000.00.
What companies are similar to ISPC?
Notable peers in the same industry include IQV (IQVIA Holdings Inc.), INCY (Incyte Corp.), MEDP (Medpace Holdings Inc.), PPD (PPD, Inc.), CRL (Charles River Laboratories International Inc.). Compare ISPC side-by-side with any of them on Quantisnow.
How can I track ISPC on Quantisnow?
Quantisnow aggregates iSpecimen Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ISPC to receive live email and push alerts on every new disclosure.